BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29944972)

  • 21. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation.
    Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
    Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of
    Lee M; Cheon K; Chae B; Hwang H; Kim HK; Chung YJ; Song JY; Cho HH; Kim JH; Kim MR
    Int J Med Sci; 2018; 15(2):124-128. PubMed ID: 29333096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.
    Kämpjärvi K; Kim NH; Keskitalo S; Clark AD; von Nandelstadh P; Turunen M; Heikkinen T; Park MJ; Mäkinen N; Kivinummi K; Lintula S; Hotakainen K; Nevanlinna H; Hokland P; Böhling T; Bützow R; Böhm J; Mecklin JP; Järvinen H; Kontro M; Visakorpi T; Taipale J; Varjosalo M; Boyer TG; Vahteristo P
    Prostate; 2016 Jan; 76(1):22-31. PubMed ID: 26383637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MED12 mutations in uterine leiomyomas: prediction of volume reduction by gonadotropin-releasing hormone agonists.
    Nagai K; Asano R; Sekiguchi F; Asai-Sato M; Miyagi Y; Miyagi E
    Am J Obstet Gynecol; 2023 Feb; 228(2):207.e1-207.e9. PubMed ID: 36150519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution melting analysis of MED12 mutations in uterine leiomyomas in Chinese patients.
    Wang H; Ye J; Qian H; Zhou R; Jiang J; Ye L
    Genet Test Mol Biomarkers; 2015 Mar; 19(3):162-6. PubMed ID: 25615570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.
    McGuire MM; Yatsenko A; Hoffner L; Jones M; Surti U; Rajkovic A
    PLoS One; 2012; 7(3):e33251. PubMed ID: 22428002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas.
    Kämpjärvi K; Mäkinen N; Mehine M; Välipakka S; Uimari O; Pitkänen E; Heinonen HR; Heikkinen T; Tolvanen J; Ahtikoski A; Frizzell N; Sarvilinna N; Sjöberg J; Bützow R; Aaltonen LA; Vahteristo P
    Br J Cancer; 2016 Jun; 114(12):1405-11. PubMed ID: 27187686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.
    Heinonen HR; Pasanen A; Heikinheimo O; Tanskanen T; Palin K; Tolvanen J; Vahteristo P; Sjöberg J; Pitkänen E; Bützow R; Mäkinen N; Aaltonen LA
    Sci Rep; 2017 Apr; 7(1):1015. PubMed ID: 28432313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.
    Di Tommaso S; Tinelli A; Malvasi A; Massari S
    Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata).
    Rieker RJ; Agaimy A; Moskalev EA; Hebele S; Hein A; Mehlhorn G; Beckmann MW; Hartmann A; Haller F
    Pathology; 2013 Jun; 45(4):388-92. PubMed ID: 23635816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonally related uterine leiomyomas are common and display branched tumor evolution.
    Mehine M; Heinonen HR; Sarvilinna N; Pitkänen E; Mäkinen N; Katainen R; Tuupanen S; Bützow R; Sjöberg J; Aaltonen LA
    Hum Mol Genet; 2015 Aug; 24(15):4407-16. PubMed ID: 25964426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients.
    Osinovskaya NS; Malysheva OV; Shved NY; Ivashchenko TE; Sultanov IY; Efimova OA; Yarmolinskaya MI; Bezhenar VF; Baranov VS
    Int J Gynecol Pathol; 2016 Nov; 35(6):509-515. PubMed ID: 26630226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive screening for MED12 mutations in gynaecological mesenchymal tumours identified morphologically distinctive mixed epithelial and stromal tumours.
    Yuan CT; Huang WC; Lee CH; Lin MC; Lee CH; Kao YC; Huang HY; Kuo KT; Lee JC
    Histopathology; 2017 May; 70(6):954-965. PubMed ID: 28002623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
    Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
    Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas.
    Mäkinen N; Heinonen HR; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA
    Br J Cancer; 2014 Apr; 110(9):2246-9. PubMed ID: 24642626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients.
    Mäkinen N; Heinonen HR; Moore S; Tomlinson IP; van der Spuy ZM; Aaltonen LA
    Oncotarget; 2011 Dec; 2(12):966-9. PubMed ID: 22182697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.
    Mäkinen N; Mehine M; Tolvanen J; Kaasinen E; Li Y; Lehtonen HJ; Gentile M; Yan J; Enge M; Taipale M; Aavikko M; Katainen R; Virolainen E; Böhling T; Koski TA; Launonen V; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA
    Science; 2011 Oct; 334(6053):252-5. PubMed ID: 21868628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Expression of MED12-Associated Coding RNA Transcripts in Uterine Leiomyomas.
    Chuang TD; Gao J; Quintanilla D; McSwiggin H; Boos D; Yan W; Khorram O
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MED12 exon 2 mutations in phyllodes tumors of the breast.
    Nagasawa S; Maeda I; Fukuda T; Wu W; Hayami R; Kojima Y; Tsugawa K; Ohta T
    Cancer Med; 2015 Jul; 4(7):1117-21. PubMed ID: 25865354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomics of uterine leiomyomas: insights from high-throughput sequencing.
    Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P
    Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.